TRISALUS LIFE SCIENCES INC TLSIW
*W EXP 08/10/202 · Equity WRT · CUSIP 89680M119
- SectorHealth care
- IndustrySurgical & Medical Instruments & Apparatus
- HeadquartersWestminster, CO
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $1.31.
Trends to Q2 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q2 2023 | 0 |
| Q3 2023 | 21 |
| Q4 2023 | 24 |
| Q1 2024 | 23 |
| Q2 2024 | 20 |
| Q3 2024 | 9 |
| Q4 2024 | 9 |
| Q1 2025 | 7 |
| Q2 2025 | 6 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2023 | 21 | 0 |
| Q4 2023 | 6 | 5 |
| Q1 2024 | 8 | 7 |
| Q2 2024 | 3 | 10 |
| Q3 2024 | 3 | 15 |
| Q4 2024 | 2 | 5 |
| Q1 2025 | 1 | 5 |
| Q2 2025 | 2 | 3 |
Biggest buyers
| CITADEL ADVISORS LLC | New | +23.5k |
| TORONTO DOMINION BANK | New | +9.4k |
Biggest sellers
| Foster Victor Wealth Advisors, LLC | Sold out | -12.6k |
| WOLVERINE ASSET MANAGEMENT LLC | Sold out | -8.7k |
| BANK OF AMERICA CORP /DE/ | Sold out | -176 |
Insider purchases and sales in Q2 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2023 | 0 | — | 0 | — | — |
| Q4 2023 | 0 | — | 0 | — | — |
| Q1 2024 | 0 | — | 0 | — | — |
| Q2 2024 | 0 | — | 0 | — | — |
| Q3 2024 | 1 | $100.2k | 1 | $50 | — |
| Q4 2024 | 1 | $69.8k | 2 | $112.1k | — |
| Q1 2025 | 3 | $422.8k | 0 | — | — |
| Q2 2025 | 0 | — | 4 | $103.9k | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2025-05-19 | Stevens Jennifer Chief Regulatory Officer | Sold | $45.1k8.7k shares |
| 2025-05-19 | Marshak Richard Chief Commercial Officer | Sold | $34.2k6.6k shares |
| 2025-05-19 | Devlin Jodi Chief of Clinical Operations | Sold | $24.7k4.8k shares |
| 2025-05-19 | Cox Bryan F. Chief of Research | Sold | $24.7k4.8k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q2 2025
| Manager | Shares | Change |
|---|---|---|
| Graypoint LLC 0.06% of their portfolio | 827.6k $1.1m | Unchanged |
| Vestcor Inc 0.00% of their portfolio | 70.8k $102.0k | Unchanged |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 23.5k $30.4k | New |
| B & T Capital Management DBA Alpha Capital Management 0.00% of their portfolio | 22.2k $28.9k | Unchanged |
| TORONTO DOMINION BANK 0.00% of their portfolio | 9.4k $12.1k | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. — of their portfolio | 0 $0 | Unchanged |